The Family Firm’s iShares US Healthcare ETF IYH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-3,602
Closed -$234K – 217
2024
Q3
$234K Sell
3,602
-629
-15% -$40.2K 0.05% 189
2024
Q2
$259K Sell
4,231
-481
-10% -$28.9K 0.06% 173
2024
Q1
$292K Buy
4,712
+12
+0.3% +$722 0.07% 159
2023
Q4
$269K Buy
+4,700
New +$256K 0.07% 159
2023
Q2
– Sell
-4,095
Closed -$224K – 186
2023
Q1
$224K Buy
4,095
+10
+0.2% +$549 0.06% 168
2022
Q4
$232K Buy
4,085
+30
+0.7% +$1.66K 0.07% 166
2022
Q3
$205K Hold
4,055
– – 0.07% 167
2022
Q2
$218K Buy
4,055
+10
+0.2% +$549 0.06% 173
2022
Q1
$234K Buy
4,045
+10
+0.2% +$558 0.06% 166
2021
Q4
$243K Sell
4,035
-245
-6% -$14K 0.06% 166
2021
Q3
$242K Buy
4,280
+15
+0.4% +$858 0.06% 162
2021
Q2
$233K Buy
4,265
+20
+0.5% +$1.06K 0.06% 161
2021
Q1
$214K Hold
4,245
– – 0.06% 166
2020
Q4
$216K Sell
4,245
-315
-7% -$14.9K 0.06% 158
2020
Q3
$207K Buy
+4,560
New +$206K 0.07% 135
2020
Q2
– Sell
-5,730
Closed -$215K – 141
2020
Q1
$215K Sell
5,730
-140
-2% -$5.76K 0.09% 124
2019
Q4
$253K Buy
+5,870
New +$237K 0.09% 133

Other funds holding IYH

The Family Firm's IYH Position: Q4 2024 in Review

The Family Firm sold out of iShares US Healthcare ETF (IYH) in Q4 2024, closing a stake of 3,602 shares — an estimated $234K sold.

The Family Firm first reported a position in IYH in Q4 2019 and held it in 17 quarters. The position peaked at $292K in Q1 2024. 507 funds tracked by Wall St. Rank hold IYH as of Q4 2024.

  • The Family Firm reported no remaining iShares US Healthcare ETF position as of Q4 2024 after selling out during the quarter.
  • The Family Firm sold 3,602 iShares US Healthcare ETF shares in Q4 2024, an estimated $234K.
  • The Family Firm first reported a position in iShares US Healthcare ETF in Q4 2019 and held it in 17 quarters.
  • The Family Firm's iShares US Healthcare ETF position peaked at $292K in Q1 2024.
  • 507 funds tracked by Wall St. Rank held iShares US Healthcare ETF as of Q4 2024.

Based on The Family Firm's 13F filing for Q4 2024, filed 10 Feb 2025.